Loading clinical trials...
Loading clinical trials...
Efficacy of Consolidative Involved-site Radiotherapy Following Sufficient Chemotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma: Wuhan University Cancer Center -NHL03 Trial
Conditions
Interventions
Consolidation involved-site radiotherapy (ISRT)
Consolidation involved-field radiotherapy (IFRT)
+4 more
Locations
1
China
DiDeng
Wuhan, Hubei, China
Start Date
October 1, 2015
Primary Completion Date
October 1, 2019
Completion Date
October 1, 2025
Last Updated
December 14, 2015
NCT05139017
NCT01804686
NCT05755087
NCT04739813
NCT06785818
NCT06043011
Lead Sponsor
Wuhan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions